Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.440
-0.020 (-0.81%)
At close: Aug 13, 2025, 4:00 PM
2.590
+0.150 (6.15%)
After-hours: Aug 13, 2025, 7:33 PM EDT
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $4.54 million as of August 13, 2025. Its market cap has decreased by -19.00% in one year.
Market Cap
4.54M
Enterprise Value
39.92M
1-Year Change
-19.00%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $4.54M, a decrease of -98.37%. That is a compound annual growth rate of -40.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.50M | 29.63% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |